Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Financial Fact:
Cost of goods sold: 201.4M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $888.5 million versus the consensus estimate of $867.09 million.
GUIDANCE:
Edwards Lifesciences sees Q1 2018 EPS of $1.04-$1.14. Edwards Lifesciences sees Q1 2018 revenue of $3.5-3.9 billion.
Edwards Lifesciences sees FY2018 EPS of $4.43-$4.63. Edwards Lifesciences sees FY2018 revenue of $900-950 million.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Edwards Lifesciences (EW) Tops Q3 EPS by 6c; raises guidance
- ITT Inc (ITT) Tops Q3 EPS by 18c ; Offers Guidance
- Wolfspeed (WOLF) Misses Q1 EPS by 147c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
